Skip to main content
Clinical Trials/ACTRN12624000483550
ACTRN12624000483550
Not yet recruiting
未知

Application of a clinical support tool in active surveillance for low risk thyroid cancer

Department of Endocrinology, Royal North Shore Hospital0 sites80 target enrollmentApril 19, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Endocrinology, Royal North Shore Hospital
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 19, 2024
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Endocrinology, Royal North Shore Hospital

Eligibility Criteria

Inclusion Criteria

  • Participants will be eligible for inclusion in the study if all of the below are met:
  • Age 18 or above
  • Thyroid nodule 2cm or smaller
  • Bethesda III, V or Bethesda VI result on FNA cytopathology
  • Clinicians will be eligible for inclusion if they are involved in the treatment of patients with thyroid cancer.

Exclusion Criteria

  • Participants will be excluded from study if:
  • Thyroid nodule \>2cm in size
  • Bethesda result other than BIII, BV or BVI
  • If they are unable to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials